Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Desmosomes01:05

Desmosomes

7.9K
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are  essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
7.9K
Surface Membrane Barriers01:18

Surface Membrane Barriers

3.0K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.0K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.3K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.3K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.7K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.7K
Tissue Membranes01:27

Tissue Membranes

8.6K
A tissue membrane is a thin layer of cells that covers the outside of the body, the organs, internal passageways that lead to the exterior of the body, and the lining of the moveable joint cavities. There are two basic types of tissue membranes— connective tissue and epithelial membranes.
Connective Tissue Membranes
The connective tissue membrane is formed solely from connective tissue. These membranes encapsulate organs, such as the kidneys, and line our movable joints. A synovial...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Mast cell-deficient mice <i>Mcpt5Cre/Dicer</i> <sup></sup> redefine the role of mast cells in experimental bullous pemphigoid.

Skin health and disease·2022
Same author

Annular plaques on the back.

Clinical and experimental dermatology·2022
Same author

COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation.

The British journal of dermatology·2021
Same author

European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Related Experiment Video

Updated: Feb 16, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.2K

[Mucous membrane pemphigoid].

M M Holtsche1, D Zillikens2, E Schmidt2

  • 1Klinik für Dermatologie, Allergologie und Venerologie, Universität zu Lübeck, Ratzeburger Allee 160, 23558, Lübeck, Deutschland. MaikeMarleen.Holtsche@uksh.de.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|December 16, 2017
PubMed
Summary
This summary is machine-generated.

Mucous membrane pemphigoid (MMP) is an autoimmune disease affecting mucous membranes. Diagnosis involves clinical signs and immunofluorescence, with various treatments available for effective patient management.

Keywords:
AutoantibodiesBasal membrane zoneImmunofluorescenceImmunosuppressionMucous membrane erosions

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.9K
Application of a Mouse Ligated Peyer&#8217;s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells
05:59

Application of a Mouse Ligated Peyer’s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells

Published on: December 17, 2011

20.2K

Related Experiment Videos

Last Updated: Feb 16, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.2K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.9K
Application of a Mouse Ligated Peyer&#8217;s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells
05:59

Application of a Mouse Ligated Peyer’s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells

Published on: December 17, 2011

20.2K

Area of Science:

  • Immunodermatology
  • Autoimmune Blistering Diseases

Background:

  • Mucous membrane pemphigoid (MMP) is characterized by autoantibodies targeting the dermal-epidermal junction, primarily affecting mucous membranes.
  • Diagnosis relies on clinical presentation and direct immunofluorescence microscopy of perilesional biopsies, revealing linear IgG, IgA, or C3 deposits at the dermal-epidermal junction.

Purpose of the Study:

  • To outline the diagnostic criteria and therapeutic strategies for mucous membrane pemphigoid.
  • To emphasize the importance of multidisciplinary collaboration in managing MMP patients.

Main Methods:

  • Diagnosis confirmed by clinical evaluation and direct immunofluorescence microscopy.
  • Detection of circulating autoantibodies using indirect immunofluorescence on salt-split human skin, ELISA, and immunoblotting.
  • Systemic treatments include corticosteroids, dapsone, mycophenolate, and azathioprine; severe cases may require cyclophosphamide, rituximab, IVIg, or immunoadsorption.

Main Results:

  • MMP diagnosis is established through characteristic clinical findings and immunopathological evidence.
  • Circulating autoantibodies are detectable in a majority of MMP patients.
  • A range of immunosuppressive therapies are effective, with tailored approaches for severe or rapidly progressing disease.

Conclusions:

  • Successful management of MMP necessitates a comprehensive diagnostic approach and individualized treatment strategies.
  • Close collaboration among various medical specialists is crucial for optimal patient outcomes in mucous membrane pemphigoid.